BackNabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc Total Revenue

Revenue analysis for NBRV.

Quarterly Revenue

$7.59M
↓ 1.03% YoY

As of Mar 2023

Annual Revenue (TTM)

$35.59M
↑ 8.66% YoY

Trailing 12 months ending Mar 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin